Hester E. de Melker

860 total citations
25 papers, 502 citations indexed

About

Hester E. de Melker is a scholar working on Infectious Diseases, Epidemiology and Health. According to data from OpenAlex, Hester E. de Melker has authored 25 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 12 papers in Epidemiology and 9 papers in Health. Recurrent topics in Hester E. de Melker's work include Vaccine Coverage and Hesitancy (9 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and Bacterial Infections and Vaccines (7 papers). Hester E. de Melker is often cited by papers focused on Vaccine Coverage and Hesitancy (9 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and Bacterial Infections and Vaccines (7 papers). Hester E. de Melker collaborates with scholars based in Netherlands, United States and Sweden. Hester E. de Melker's co-authors include Mirjam Kretzschmar, Brechje de Gier, Mirjam J. Knol, Marie‐Josée J. Mangen, Susan Hahné, Frits R. Mooi, J. F. P. Schellekens, Joop Schellekens, Susan van den Hof and Stijn P. Andeweg and has published in prestigious journals such as Nature Communications, PLoS ONE and American Journal of Epidemiology.

In The Last Decade

Hester E. de Melker

24 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hester E. de Melker Netherlands 13 266 189 116 102 97 25 502
A. Angelica Trujillo United States 7 446 1.7× 365 1.9× 86 0.7× 70 0.7× 79 0.8× 8 799
Núria Soldevila Spain 17 173 0.7× 587 3.1× 111 1.0× 90 0.9× 49 0.5× 63 724
Ana Navascués Spain 18 438 1.6× 503 2.7× 158 1.4× 32 0.3× 143 1.5× 67 911
Ian D. Plumb United States 12 322 1.2× 166 0.9× 107 0.9× 38 0.4× 96 1.0× 42 596
Sophy Goren Israel 15 393 1.5× 129 0.7× 103 0.9× 69 0.7× 30 0.3× 33 688
Emilia Lupulescu Romania 12 243 0.9× 532 2.8× 118 1.0× 31 0.3× 66 0.7× 28 711
Jane Gidudu United States 13 233 0.9× 252 1.3× 197 1.7× 97 1.0× 14 0.1× 30 570
Masayoshi Shinjoh Japan 16 280 1.1× 545 2.9× 52 0.4× 110 1.1× 37 0.4× 57 711
Adrienne Guignard Belgium 12 124 0.5× 310 1.6× 108 0.9× 81 0.8× 29 0.3× 34 569
Martine Sabbe Belgium 14 242 0.9× 293 1.6× 136 1.2× 49 0.5× 29 0.3× 25 504

Countries citing papers authored by Hester E. de Melker

Since Specialization
Citations

This map shows the geographic impact of Hester E. de Melker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hester E. de Melker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hester E. de Melker more than expected).

Fields of papers citing papers by Hester E. de Melker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hester E. de Melker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hester E. de Melker. The network helps show where Hester E. de Melker may publish in the future.

Co-authorship network of co-authors of Hester E. de Melker

This figure shows the co-authorship network connecting the top 25 collaborators of Hester E. de Melker. A scholar is included among the top collaborators of Hester E. de Melker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hester E. de Melker. Hester E. de Melker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eilers, Renske, Floris H. Groenendijk, Nynke Y. Rots, et al.. (2025). Influence of perceived influenza-like symptoms on intention to receive seasonal influenza vaccination. BMC Public Health. 25(1). 1124–1124. 2 indexed citations
2.
Andeweg, Stijn P., Maarten Schipper, Hester E. de Melker, et al.. (2025). Prospective cohort study of fatigue before and after SARS-CoV-2 infection in the Netherlands. Nature Communications. 16(1). 1923–1923. 1 indexed citations
3.
Andeweg, Stijn P., Maarten Schipper, Diederick E. Grobbee, et al.. (2025). Post-COVID-19 condition in individuals infected with SARS-CoV-2 in autumn 2023 in the Netherlands: a prospective cohort study with pre- and post-infection data. The Lancet Regional Health - Europe. 59. 101472–101472.
4.
Gier, Brechje de, Jan van de Kassteele, Liselotte van Asten, et al.. (2024). Attribution of invasive group A streptococcal infections (iGAS) to predisposing viral infections, the Netherlands, 2010 to 2023. Eurosurveillance. 29(40). 3 indexed citations
5.
Bekker, Mireille N., Hester E. de Melker, Gerco den Hartog, et al.. (2024). Maternal Pertussis Immunization and Immunoglobulin G Levels in Early- to Late-Term and Preterm Infants. JAMA Network Open. 7(7). e2424608–e2424608. 4 indexed citations
6.
Gier, Brechje de, Hester E. de Melker, Susan Hahné, et al.. (2023). Effectiveness of bivalent mRNA booster vaccination against SARS-CoV-2 Omicron infection, the Netherlands, September to December 2022. Eurosurveillance. 28(7). 18 indexed citations
7.
Gier, Brechje de, Stijn P. Andeweg, Jantien A. Backer, et al.. (2021). Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), the Netherlands, August to September 2021. Eurosurveillance. 26(44). 52 indexed citations
8.
Verberk, Janneke D. M., Jan van de Kassteele, Nick Andrews, et al.. (2021). Impact analysis of rotavirus vaccination in various geographic regions in Western Europe. Vaccine. 39(45). 6671–6681. 8 indexed citations
10.
Gier, Brechje de, Stijn P. Andeweg, Ronald ter Schegget, et al.. (2021). Vaccine effectiveness against SARS-CoV-2 transmission and infections among household and other close contacts of confirmed cases, the Netherlands, February to May 2021. Eurosurveillance. 26(31). 51 indexed citations
11.
Maas, Nicoline van der, et al.. (2019). Pertussis hospitalizations among term and preterm infants: clinical course and vaccine effectiveness. BMC Infectious Diseases. 19(1). 919–919. 14 indexed citations
12.
Lier, Alies van, Scott McDonald, Martijn Bouwknegt, et al.. (2016). Disease Burden of 32 Infectious Diseases in the Netherlands, 2007-2011. PLoS ONE. 11(4). e0153106–e0153106. 64 indexed citations
13.
Greeff, Sabine C. de, Peter Teunis, Hester E. de Melker, et al.. (2012). Two-Component Cluster Analysis of a Large Serodiagnostic Database for Specificity of Increases of IgG Antibodies against Pertussis Toxin in Paired Serum Samples and of Absolute Values in Single Serum Samples. Clinical and Vaccine Immunology. 19(9). 1452–1456. 12 indexed citations
14.
Zomer, Tizza P., Y. T. H. P. VAN DUYNHOVEN, Marie‐Josée J. Mangen, et al.. (2008). Assessing the introduction of universal rotavirus vaccination in the Netherlands. Vaccine. 26(29-30). 3757–3764. 27 indexed citations
15.
Boot, Hein J., Iris Wallenburg, Hester E. de Melker, et al.. (2007). Assessing the introduction of universal human papillomavirus vaccination for preadolescent girls in The Netherlands. Vaccine. 25(33). 6245–6256. 38 indexed citations
16.
Boven, Michiel van, Frits R. Mooi, Joop Schellekens, Hester E. de Melker, & Mirjam Kretzschmar. (2005). Pathogen adaptation under imperfect vaccination: implications for pertussis. Proceedings of the Royal Society B Biological Sciences. 272(1572). 1617–1624. 41 indexed citations
17.
Greeff, Sabine C. de, J. F. P. Schellekens, Frits R. Mooi, & Hester E. de Melker. (2005). [Effect of vaccination against pertussis on the incidence of pertussis in The Netherlands, 1996-2003].. PubMed. 149(17). 937–43. 13 indexed citations
18.
Nagelkerke, Nico, et al.. (2003). Estimating the incidence of subclinical infections withLegionella Pneumoniausing data augmentation: analysis of an outbreak in The Netherlands. Statistics in Medicine. 22(24). 3713–3724. 12 indexed citations
19.
Teunis, Peter, et al.. (2002). Kinetics of the IgG antibody response to pertussis toxin after infection with B. pertussis. Epidemiology and Infection. 129(3). 479–489. 50 indexed citations
20.
Spaendonck, M.A.E. Conyn-van, et al.. (2001). Immunity to Poliomyelitis in the Netherlands. American Journal of Epidemiology. 153(3). 207–214. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026